These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 37797784)
1. Quality by design for sumatriptan loaded nano-ethosomal mucoadhesive gel for the therapeutic management of nitroglycerin induced migraine. Shafique U; Din FU; Sohail S; Batool S; Almari AH; Lahiq AA; Fatease AA; Alharbi HM Int J Pharm; 2023 Nov; 646():123480. PubMed ID: 37797784 [TBL] [Abstract][Full Text] [Related]
2. Development and Evaluation of in-situ Nasal Gel Formulations of Nanosized Transferosomal Sumatriptan: Design, Optimization, in vitro and in vivo Evaluation. Omar MM; Eleraky NE; El Sisi AM; Ali Hasan O Drug Des Devel Ther; 2019; 13():4413-4430. PubMed ID: 31920290 [TBL] [Abstract][Full Text] [Related]
3. Intranasal drug delivery of sumatriptan succinate-loaded polymeric solid lipid nanoparticles for brain targeting. Yadav RK; Shah K; Dewangan HK Drug Dev Ind Pharm; 2022 Jan; 48(1):21-28. PubMed ID: 35703403 [TBL] [Abstract][Full Text] [Related]
4. Intranasal In Situ Gel of Apixaban-Loaded Nanoethosomes: Preparation, Optimization, and In Vivo Evaluation. El-Shenawy AA; Mahmoud RA; Mahmoud EA; Mohamed MS AAPS PharmSciTech; 2021 May; 22(4):147. PubMed ID: 33948767 [TBL] [Abstract][Full Text] [Related]
5. Thermoreversible nanoethosomal gel for the intranasal delivery of Eletriptan hydrobromide. Shelke S; Shahi S; Jadhav K; Dhamecha D; Tiwari R; Patil H J Mater Sci Mater Med; 2016 Jun; 27(6):103. PubMed ID: 27091045 [TBL] [Abstract][Full Text] [Related]
6. Nose-to-brain delivery of sumatriptan-loaded nanostructured lipid carriers: preparation, optimization, characterization and pharmacokinetic evaluation. Masjedi M; Azadi A; Heidari R; Mohammadi-Samani S J Pharm Pharmacol; 2020 Oct; 72(10):1341-1351. PubMed ID: 32579251 [TBL] [Abstract][Full Text] [Related]
8. Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation. Galgatte UC; Kumbhar AB; Chaudhari PD Drug Deliv; 2014 Feb; 21(1):62-73. PubMed ID: 24191774 [TBL] [Abstract][Full Text] [Related]
9. The pharmacodynamics of sumatriptan in nitroglycerin-induced headache. Fullerton T; Komorowski-Swiatek D; Forrest A; Gengo FM J Clin Pharmacol; 1999 Jan; 39(1):17-29. PubMed ID: 9987697 [TBL] [Abstract][Full Text] [Related]
10. Rapid absorption of sumatriptan powder and effects on glyceryl trinitrate model of headache following intranasal delivery using a novel bi-directional device. Luthringer R; Djupesland PG; Sheldrake CD; Flint A; Boeijinga P; Danjou P; Demazières A; Hewson G J Pharm Pharmacol; 2009 Sep; 61(9):1219-28. PubMed ID: 19703372 [TBL] [Abstract][Full Text] [Related]
14. Harnessing Intranasal Delivery Systems of Sumatriptan for the Treatment of Migraine. Assadpour S; Shiran MR; Asadi P; Akhtari J; Sahebkar A Biomed Res Int; 2022; 2022():3692065. PubMed ID: 35075426 [TBL] [Abstract][Full Text] [Related]
15. Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion. Abdou EM; Kandil SM; Miniawy HMFE Int J Pharm; 2017 Aug; 529(1-2):667-677. PubMed ID: 28729175 [TBL] [Abstract][Full Text] [Related]
16. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569 [TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacokinetics of intranasal sumatriptan. Fuseau E; Petricoul O; Moore KH; Barrow A; Ibbotson T Clin Pharmacokinet; 2002; 41(11):801-11. PubMed ID: 12190330 [TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study). Cady RK; McAllister PJ; Spierings EL; Messina J; Carothers J; Djupesland PG; Mahmoud RA Headache; 2015 Jan; 55(1):88-100. PubMed ID: 25355310 [TBL] [Abstract][Full Text] [Related]
19. Innovative delivery systems for migraine: the clinical utility of a transdermal patch for the acute treatment of migraine. Rapoport AM; Freitag F; Pearlman SH CNS Drugs; 2010 Nov; 24(11):929-40. PubMed ID: 20932065 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of Brain Targeting Potential of Zolmitriptan Mucoadhesive Nanoparticles for Intranasal Drug Delivery. Jha S; Mishra D Pharm Nanotechnol; 2022; 10(2):113-124. PubMed ID: 35240970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]